Inhibikase Therapeutics $ikt CEO Discusses Parkinson's Opportunities and Potential Of The Company!
$CUBT CEO Richard Garr Gives Us Updates On The Pipeline, COVID Vaccine, and Dr. Catherine Sohn
Travis Mickle, CEO KemPharm Answers ALL Viewer Questions On $kmph Company and the Future!
$cubt Repurposed Metformin: Curative Biotechnology, Inc. Might Be The Next Penny Stock To Blow Up!
CEO Of Kintara Therapeutics $ktra Discusses His Career Path and Meeting A Massive Unmet Medical Need
Oncologist Convinced To Buy $GOVX and Hold Long Term. Small Cap With HUGE Potential in Vaccines!
Corcept Therapeutics Incorporated (CORT) Stock Analysis: Hyperfocused and Poised For Growth! Article: https://www.latinosinclinicalresearch.com/written-articles/can-company-sustain-huge-growth-rate
https://www.latinosinclinicalresearch.com/written-articles/here-are-five-fda-approval-decisions-to-watch
Dan, Ashley, Dr. Al, Chris, and Monica discuss a few biotech long term and short term plays
Dan Sfera, Chris Sauber, Ashley Margo, Monica Cuitiva, and Dr. Aljazayrly take a look at KemPharm, Inc and a potential for a better ADHD Treatment!
Dan, Chris, Ashley, Monica, and Dr Aljazayrly go in depth on some oncology and spac stocks
GLSI Stock Analysis and Clinical Breakdown By An Oncologist and Clinical Research Team: In this episode the team analyzes Greenwich Lifesciences meteoric stock rise and discuss the clinical aspects of the GP2 investigational product
Monica, Chris, and Dr. Al discuss some Alzheimer's and diabetes stocks and analyze some clinical research studies as well
Dan, Chris, Monica, and Dr. Aljazayrly analyze Regeneron's study pipeline of clinical trials and discuss the treatments and stock
The Clinical Scoop crew discuss COVID19 and it's effects on treatment management in oncology practices